Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$4.2M Sell
31,283
-5,531
-15% -$794K 0.4% 47
2022
Q2
$5.64M Buy
36,814
+3,071
+9% +$469K 0.5% 37
2022
Q1
$5.47M Sell
33,743
-4,892
-13% -$711K 0.39% 47
2021
Q4
$4.17M Hold
38,635
0.33% 59
2021
Q3
$4.17M Buy
38,635
+151
+0.4% +$17.3K 0.38% 50
2021
Q2
$4.33M Buy
38,484
+228
+0.6% +$25.7K 0.33% 50
2021
Q1
$4.14M Sell
38,256
-4,779
-11% -$511K 0.36% 54
2020
Q4
$4.61M Buy
43,035
+594
+1% +$57.1K 0.42% 44
2020
Q3
$3.72M Sell
42,441
-158
-0.4% -$14.9K 0.39% 50
2020
Q2
$4.18M Buy
42,599
+2,657
+7% +$234K 0.48% 42
2020
Q1
$3.04M Buy
39,942
+44
+0.1% +$3.75K 0.44% 45
2019
Q4
$3.53M Buy
39,898
+1,099
+3% +$91.2K 0.43% 46
2019
Q3
$2.94M Buy
38,799
+8,057
+26% +$552K 0.39% 50
2019
Q2
$2.24M Sell
30,742
-1,954
-6% -$154K 0.31% 57
2019
Q1
$2.63M Sell
32,696
-391
-1% -$32K 0.38% 51
2018
Q4
$3.05M Sell
33,087
-10,024
-23% -$882K 0.5% 46
2018
Q3
$4.08M Sell
43,111
-125
-0.3% -$11.9K 0.58% 37
2018
Q2
$4.01M Sell
43,236
-7,261
-14% -$709K 0.61% 39
2018
Q1
$4.78M Buy
50,497
+40,987
+431% +$4.5M 0.75% 32
2017
Q4
$920K Buy
9,510
+207
+2% +$19.5K 0.21% 80
2017
Q3
$827K Sell
9,303
-3,250
-26% -$247K 0.19% 89
2017
Q2
$910K Sell
12,553
-1
-0% -$67 0.21% 86
2017
Q1
$818K Sell
12,554
-2,736
-18% -$172K 0.19% 96
2016
Q4
$957K Sell
15,290
-461
-3% -$28.1K 0.22% 90
2016
Q3
$993K Buy
15,751
+62
+0.4% +$4.01K 0.22% 94
2016
Q2
$971K Sell
15,689
-714
-4% -$43.5K 0.22% 93
2016
Q1
$937K Buy
16,403
+194
+1% +$10.8K 0.21% 93
2015
Q4
$960K Buy
16,209
+936
+6% +$53.9K 0.19% 91
2015
Q3
$831K Buy
15,273
+7,915
+108% +$515K 0.18% 97
2015
Q2
$494K Buy
7,358
+2,454
+50% +$160K 0.12% 116
2015
Q1
$287K Sell
4,904
-123
-2% -$7.43K 0.08% 121
2014
Q4
$329K Buy
5,027
+276
+6% +$17.4K 0.09% 120
2014
Q3
$274K Buy
4,751
+857
+22% +$47.6K 0.1% 98
2014
Q2
$220K Buy
+3,894
New +$204K 0.08% 113

Other funds holding ABBV

CPWM LLC's ABBV Position: Q3 2022 in Review

CPWM LLC reduced its AbbVie (ABBV) stake by 15% in Q3 2022, selling an estimated $794K and leaving 31,283 shares worth $4.2M. The position accounts for 0.4% of the portfolio, ranked #47.

CPWM LLC first reported a position in ABBV in Q2 2014 and has held it in 34 quarters since. The position peaked at $5.64M in Q2 2022. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • CPWM LLC held 31,283 shares of AbbVie worth $4.2M as of Q3 2022.
  • CPWM LLC sold 5,531 AbbVie shares in Q3 2022, an estimated $794K.
  • AbbVie made up 0.4% of CPWM LLC's portfolio in Q3 2022, its #47 holding.
  • CPWM LLC first reported a position in AbbVie in Q2 2014 and has held it in 34 quarters since.
  • CPWM LLC's AbbVie position peaked at $5.64M in Q2 2022.
  • 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on CPWM LLC's 13F filing for Q3 2022, filed 14 Nov 2022.